US Patent 10668074 Uses of DPP IV inhibitors

Patent 10668074 was granted and assigned to Boehringer Ingelheim on June, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Boehringer Ingelheim

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10668074

Date of Patent

June 2, 2020

Patent Application Number

16103096

Date Filed

August 14, 2018

Patent Citations

‌

US Patent 10023574 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

‌

US Patent 10301313 Polymorphs

Patent Primary Examiner

‌

Kevin E. Weddington

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10668074 Uses of DPP IV inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API